QNRX logo

QNRX Quoin Pharmaceuticals, Ltd.

NASDAQ Capital Market · Biotechnology · Healthcare

$3.28
-0.08 (-2.35%)

Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, …

Market Cap: $6.59Mquoinpharma.com

Price

No data yet.

Social Signal Score

52
5d
—
30d
55
2 mentions
—
60d
53
4 mentions
—
90d
48
5 mentions
—
news: 5

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$17+418.3%
Low $14Median $17High $20
Current Consensus

Revenue

$0.00
$0.00
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-20.16
$-26.52–$-13.79
1 analysts
FY2026
$-5.16
$-6.79–$-3.53
2 analysts
FY2027
$-2.40
$-3.10–$-1.70
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Michael Myers
Sector
Healthcare
Industry
Biotechnology
Employees
4
Beta
1.72
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-3.69
quoinpharma.com